Release  date:      March 7, 2024 
  Expiration  date:     March 6, 2027
Estimated Time of Completion: 1 hour
		Description
        				Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
			  
	
		
Learning Objectives
	
    
	
	
    After  completing this case the reader should be able to:
  - Perform  a postmenopausal risk assessment that includes vasomotor symptoms, symptoms of  genitourinary syndrome of menopause, and osteoporosis in estrogen-deficient  postmenopausal women. 
- Appropriately  select hormone therapy, particularly estrogen-alone therapy, for postmenopausal  women without a uterus. 
- Counsel  postmenopausal women regarding the risks and benefits of, and alternatives to,  hormone therapy. 
- Summarize  changes in the updated North American Menopause Society guidelines on  menopause, especially regarding hormone therapy. 
- Describe  the effectiveness of hormone therapy for vasomotor symptoms and symptoms  of the genitourinary syndrome of menopause, as well as for bone loss and  fracture prevention. 
 
	 
 
	
		
Target Audience
	
	
	
		Directed to primary care physicians including family practitioners and internists.
 
	 
 
	
		
Accreditation
	
	
	
        
In support of improving patient  care, Cleveland Clinic Center for Continuing Education is jointly accredited by  the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation  Council for Pharmacy Education (ACPE), and the American Nurses Credentialing  Center (ANCC), to provide continuing education for the healthcare team. 
American  Medical Association (AMA)
  Cleveland  Clinic Center for Continuing Education designates this enduring activity for a  maximum of 1.0 AMA  PRA Category 1 Credits™. Physicians should claim only the credit  commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this  activity may submit the credit hours to the American Osteopathic Association  for Category 2 credit.
ABIM MOC:  Successful  completion of this CME activity, which includes participation in the evaluation  component, enables the participant to earn up to 1.0  Medical  Knowledge MOC points in the American Board of Internal Medicine's (ABIM)  Maintenance of Certification (MOC) program. It is the CME activity provider's  responsibility to submit participant completion information to ACCME for the  purpose of granting ABIM MOC credit.
  Your  credit will be reported to the ABIM within 30 days of claiming credit.  
        
         
	 
 
	
		
Activity Director and Faculty
	
	
	
    		Activity Director
	Anthony Fernandez, MD, PhD
	 Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Medical Co-Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH
	
        
Steven Kawczak, PhD, CHCP, FACEHP
  Assistant Professor of Medicine, Cleveland  Clinic Lerner College of Medicine of CWRU
  Co-Director, Center for Continuing Education
  Staff, Center for Educational Resources
  Education Institute
  Cleveland  Clinic
  Cleveland,  OH
        
        
	Faculty
Holly  L. Thacker, MD, FACP, MSCP, CCD 
  Center  for Specialized Women's Health 
  Cleveland  Clinic
  Cleveland,  OH
	 
	 
 
	
		
CME Disclaimer
	
	
	
    	The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
 
	 
 
Disclosures
	In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
    The following faculty has indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:
 
  
    | Anthony Fernandez, MD, PhD | 
  
    | Bristol-Myers      Squibb Co., UCB, Inc. | Consulting | 
  
    | Pfizer, Inc. | Research /      Independent Contractor | 
  
    | Mallinckrodt      Inc., Novartis | ConsultingResearch / Independent Contractor
 Teaching and Speaking
 | 
  
    | Abbvie      Pharmaceuticals | ConsultingResearch / Independent Contractor
 Advisor or review panel participant
 Teaching and Speaking
 | 
  
    | Kyowa Kirin | Teaching and      Speaking | 
        
 
  
    | Holly Thacker, MD | 
  
    | Abbvie    Pharmaceuticals, Astellas Pharma US, Inc. | Consulting | 
  
    | Scynexis, Inc | Teaching and    Speaking | 
                
                
			
		
 The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
 
Steven Kawczak, PhD
 
 
				
 
This CME activity was produced by The Cleveland Clinic
  Center for Continuing Education.